60 Degrees Pharmaceuticals, Inc. – NASDAQ:SXTP
60 Degrees Pharmaceuticals stock price today
60 Degrees Pharmaceuticals stock price monthly change
60 Degrees Pharmaceuticals stock price quarterly change
60 Degrees Pharmaceuticals stock price yearly change
60 Degrees Pharmaceuticals key metrics
Market Cap | 2.68M |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | -0.15 |
Revenue | 299.52K |
EBITDA | -469.12K |
Income | -680.99K |
Revenue Q/Q | 750.76% |
Revenue Y/Y | 93.39% |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | -156.63% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for free60 Degrees Pharmaceuticals stock price history
60 Degrees Pharmaceuticals stock forecast
60 Degrees Pharmaceuticals financial statements
| Jun 2023 | 59.53K | -3.33M | -5604.64% |
|---|---|---|---|
| Sep 2023 | 51.18K | 4.18M | 8172.22% |
| Dec 2023 | 42.70K | -1.95M | -4584.98% |
| Mar 2024 | 146.09K | 430.47K | 294.65% |
| Dec 2023 | 42.70K | -1.95M | -4584.98% |
|---|---|---|---|
| Mar 2024 | 146.09K | 430.47K | 294.65% |
| Sep 2025 | 600K | -708.71K | -118.12% |
| Dec 2025 | 800K | -708.71K | -88.59% |
Analysts Price target
Financials & Ratios estimates
| 2024-04-01 | -0.27 | -0.44 |
|---|---|---|
| 2024-05-15 | -0.15 | 0.03 |
| Jun 2023 | 7358738 | 30.23M | 410.88% |
|---|---|---|---|
| Sep 2023 | 9150212 | 2.63M | 28.79% |
| Dec 2023 | 7783771 | 2.98M | 38.36% |
| Mar 2024 | 8379108 | 1.25M | 14.96% |
| Jun 2023 | -313.49K | -18.12K | 321.06K |
|---|---|---|---|
| Sep 2023 | -3.75M | -27.90K | 5.97M |
| Dec 2023 | -63.66K | -66.56K | -1 |
| Mar 2024 | -1.14M | -9.81K | 1.90M |
60 Degrees Pharmaceuticals alternative data
| Sep 2023 | 2 |
|---|---|
| Oct 2023 | 2 |
| Nov 2023 | 2 |
| Dec 2023 | 2 |
| Jan 2024 | 2 |
| Feb 2024 | 2 |
| Mar 2024 | 2 |
| Apr 2024 | 2 |
| May 2024 | 3 |
| Jun 2024 | 3 |
| Jul 2024 | 3 |
60 Degrees Pharmaceuticals other data
| Period | Buy | Sel |
|---|---|---|
| Aug 2024 | 5000 | 0 |
| Nov 2024 | 7000 | 0 |
| Dec 2024 | 86951 | 0 |
-
What's the price of 60 Degrees Pharmaceuticals stock today?
One share of 60 Degrees Pharmaceuticals stock can currently be purchased for approximately $1.29.
-
When is 60 Degrees Pharmaceuticals's next earnings date?
Unfortunately, 60 Degrees Pharmaceuticals's (SXTP) next earnings date is currently unknown.
-
Does 60 Degrees Pharmaceuticals pay dividends?
No, 60 Degrees Pharmaceuticals does not pay dividends.
-
How much money does 60 Degrees Pharmaceuticals make?
60 Degrees Pharmaceuticals has a market capitalization of 2.68M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 13.6% to 253.57K US dollars. 60 Degrees Pharmaceuticals made a loss 3.77M US dollars in net income (profit) last year or $0.03 on an earnings per share basis.
-
What is 60 Degrees Pharmaceuticals's stock symbol?
60 Degrees Pharmaceuticals, Inc. is traded on the NASDAQ under the ticker symbol "SXTP".
-
What is 60 Degrees Pharmaceuticals's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of 60 Degrees Pharmaceuticals?
Shares of 60 Degrees Pharmaceuticals can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does 60 Degrees Pharmaceuticals have?
As Jul 2024, 60 Degrees Pharmaceuticals employs 3 workers, which is 50% more then previous quarter.
-
When 60 Degrees Pharmaceuticals went public?
60 Degrees Pharmaceuticals, Inc. is publicly traded company for more then 2 years since IPO on 12 Jul 2023.
-
What is 60 Degrees Pharmaceuticals's official website?
The official website for 60 Degrees Pharmaceuticals is 60degreespharma.com.
-
Where are 60 Degrees Pharmaceuticals's headquarters?
60 Degrees Pharmaceuticals is headquartered at 1025 Connecticut Avenue NW, Washington, DC.
-
How can i contact 60 Degrees Pharmaceuticals?
60 Degrees Pharmaceuticals's mailing address is 1025 Connecticut Avenue NW, Washington, DC and company can be reached via phone at +20 2 3275422.
60 Degrees Pharmaceuticals company profile:
60 Degrees Pharmaceuticals, Inc.
60degreespharma.comNASDAQ
3
Biotechnology
Healthcare
60 Degrees Pharmaceuticals, Inc. operates as a specialty pharmaceutical company that engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases. The company offers Arakoda for malaria preventative treatment. It also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19; Tafenoquine for fungal lung infections, tick-borne diseases, candidiasis, and other infectious and non-infectious diseases; and Celgosivir for respiratory viruses and dengue. The company was founded in 2010 and is based in Washington, District of Columbia.
Washington, DC 20036
CIK: 0001946563
ISIN: US83006G1040
CUSIP: 83006G104
